Seattle Genetics | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Acadia Pharmaceuticals USD 765.24M 32.44M 2025-03
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Amgen USD 6.21B 330M 2025-03
Astellas Pharma JPY 1.51T 19.45B 2025-03
Bayer EUR 32.58B 537M 2025-03
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Celldex Therapeutics USD 702.98M 44.02M 2025-03
Daiichi Sankyo JPY 1.62T 958M 2025-03
Eisai JPY 841.42B 31.94B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Exelixis USD 2.13B 113.18M 2025-04
Genmab DKK 5.3B 31.4B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Glaxosmithkline GBP 13.67B 337M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Insmed USD 99.16M 186.22M 2025-03
MacroGenics USD 116.06M 4.01M 2024-12
Merck USD 48.34B 2.02B 2025-03
Moderna USD 10.07B 835M 2025-03
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Sanofi 74.07B 3.78B 2025-03
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
Takeda JPY 6.94T 483.19B 2025-03
Teva Pharmaceutical Industries USD 6.26B 542M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Xencor USD 639.87M 37.74M 2025-03



Seattle Genetics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.